Rockwell Medical Company Profile (NASDAQ:RMTI)

About Rockwell Medical

Rockwell Medical logoRockwell Medical, Inc. (Rockwell) is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The Company operates through the hemodialysis market segment, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceutical, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its lead branded drug, Triferic is indicated for iron maintenance. Triferic is an iron compound that is delivered to hemodialysis patients through dialysate, replacing the iron loss that occurs during their dialysis treatment. Its generic drug, Calcitriol, is indicated for treating secondary hyperparathyroidism in dialysis patients. It manufactures, sells, delivers and distributes hemodialysis concentrates, along with a range of ancillary products.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: RMTI
  • CUSIP: 77437410
Key Metrics:
  • Previous Close: $5.83
  • 50 Day Moving Average: $5.99
  • 200 Day Moving Average: $6.46
  • 52-Week Range: $3.55 - $10.58
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 194.33
  • P/E Growth: -0.79
  • Market Cap: $300.40M
  • Outstanding Shares: 51,527,000
  • Beta: 1.92
Profitability:
  • Net Margins: -37.98%
  • Return on Equity: -33.60%
  • Return on Assets: -22.85%
Debt:
  • Current Ratio: 10.91%
  • Quick Ratio: 9.31%
Additional Links:
Companies Related to Rockwell Medical:

Analyst Ratings

Consensus Ratings for Rockwell Medical (NASDAQ:RMTI) (?)
Ratings Breakdown: 2 Sell Ratings, 2 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 1.80)
Consensus Price Target: $8.00 (37.22% upside)

Analysts' Ratings History for Rockwell Medical (NASDAQ:RMTI)
Show:
DateFirmActionRatingPrice TargetDetails
11/9/2016BTIG ResearchReiterated RatingBuy$12.00View Rating Details
11/8/2016Bank of America CorpDowngradeNeutral -> Underperform$9.00 -> $5.00View Rating Details
4/6/2016Morgan StanleyReiterated RatingSellView Rating Details
3/1/2016Craig HallumDowngradeBuy -> Hold$7.00View Rating Details
3/1/2016Stifel NicolausDowngradeBuy -> HoldView Rating Details
11/12/2015Oppenheimer Holdings, Inc.Reiterated RatingOutperform$26.00View Rating Details
11/11/2015Brean CapitalReiterated RatingSell$4.00View Rating Details
(Data available from 2/22/2015 forward)

Earnings

Earnings History for Rockwell Medical (NASDAQ:RMTI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/27/2017        
11/7/2016Q3($0.10)($0.09)$15.40 million$12.81 millionViewListenView Earnings Details
8/8/2016Q2($0.10)($0.11)$13.86 million$12.50 millionViewN/AView Earnings Details
5/10/2016Q1($0.08)($0.10)$15.25 million$13.63 millionViewListenView Earnings Details
2/29/2016Q4$0.02($0.12)$19.98 million$14.10 millionViewListenView Earnings Details
11/9/2015Q315($0.02)($0.05)$14.93 million$14.40 millionViewListenView Earnings Details
8/4/2015Q215($0.10)($0.05)$11.84 million$12.96 millionViewListenView Earnings Details
5/7/2015Q414($0.10)($0.07)$13.20 million$13.90 millionViewN/AView Earnings Details
2/26/2015Q4($0.10)($0.14)$13.51 million$14.40 millionViewN/AView Earnings Details
11/10/2014Q314($0.10)($0.10)$13.40 million$13.70 millionViewN/AView Earnings Details
7/31/2014Q2($0.13)($0.08)$13.45 million$13.00 millionViewN/AView Earnings Details
5/12/2014Q1($0.14)($0.20)$14.22 million$13.00 millionViewN/AView Earnings Details
2/26/2014($0.28)($0.21)ViewN/AView Earnings Details
11/8/2012Q312($0.50)($0.86)$12.57 million$12.70 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Rockwell Medical (NASDAQ:RMTI)
Current Year EPS Consensus Estimate: $-0.38 EPS
Next Year EPS Consensus Estimate: $0.03 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.09)($0.09)($0.09)
Q2 20161($0.06)($0.06)($0.06)
Q3 20161($0.09)($0.09)($0.09)
Q4 20161($0.07)($0.07)($0.07)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Rockwell Medical (NASDAQ:RMTI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Rockwell Medical (NASDAQ:RMTI)
Insider Ownership Percentage: 15.90%
Institutional Ownership Percentage: 21.14%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/11/2016Kenneth L HoltDirectorSell19,725$5.16$101,781.00View SEC Filing  
11/1/2016Kenneth L HoltDirectorSell1,400$5.92$8,288.00View SEC Filing  
10/21/2016Kenneth L HoltDirectorSell2,533$6.04$15,299.32View SEC Filing  
9/19/2016Kenneth L HoltDirectorSell8,075$6.81$54,990.75View SEC Filing  
8/25/2016Kenneth L HoltDirectorSell9,520$6.37$60,642.40View SEC Filing  
8/16/2016Kenneth L HoltDirectorSell3,692$7.31$26,988.52View SEC Filing  
12/4/2015Ronald D. BoydDirectorSell12,500$10.58$132,250.00View SEC Filing  
8/14/2015Robert L ChioiniCEOBuy4,910$11.96$58,723.60View SEC Filing  
8/13/2015Raymond Dennis PrattVPBuy5,000$11.54$57,700.00View SEC Filing  
8/13/2015Robert L ChioiniCEOBuy5,090$11.51$58,585.90View SEC Filing  
8/27/2012David A HagelsteinMajor ShareholderBuy7,000$8.10$56,700.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Rockwell Medical (NASDAQ:RMTI)
DateHeadline
News IconInvestor Sphere: Keeping an Eye on Levels for Rockwell Medical Inc (RMTI) - Davidson Register (NASDAQ:RMTI)
davidsonregister.com - February 21 at 5:18 PM
globenewswire.com logoRockwell Medical Updates Progress on Calcitriol Commercial ... - GlobeNewswire (press release) (NASDAQ:RMTI)
globenewswire.com - February 21 at 5:18 PM
finance.yahoo.com logoRockwell Medical Updates Progress on Calcitriol Commercial Launch (NASDAQ:RMTI)
finance.yahoo.com - February 21 at 5:18 PM
finance.yahoo.com logo9:05 am Rockwell Medical updates progress on calcitriol commercial launch, stating that the FDA has requested that the Co resubmit the application for the new contract manufacturer as a Prior Approval Supplement and pay a fee for the Agency (NASDAQ:RMTI)
finance.yahoo.com - February 21 at 5:18 PM
News IconSell-side Consensus Sees Rockwell Medical, Inc. (NASDAQ:RMTI) Going Where Near-Term? - Aiken Advocate (NASDAQ:RMTI)
aikenadvocate.com - February 20 at 6:46 PM
News IconMetrics in Focus: Rockwell Medical, Inc. (NASDAQ:RMTI) - BVN (NASDAQ:RMTI)
bvnewsjournal.com - February 18 at 8:23 AM
nasdaq.com logoNotable Wednesday Option Activity: AXP, TERP, RMTI (NASDAQ:RMTI)
www.nasdaq.com - February 16 at 7:14 PM
News IconEPS Forecast Of Rockwell Medical, Inc. (NASDAQ:RMTI) Set At $-0.11 - Transcript Daily (NASDAQ:RMTI)
transcriptdaily.com - February 9 at 11:36 PM
News IconRockwell Medical, Inc. (NASDAQ:RMTI) Long-Term Growth Estimate At $20 - Transcript Daily (NASDAQ:RMTI)
transcriptdaily.com - February 6 at 12:25 AM
News IconConsensus Price Of Rockwell Medical, Inc. (NASDAQ:RMTI) Set At $4.75 - Transcript Daily (NASDAQ:RMTI)
transcriptdaily.com - February 3 at 11:20 PM
News IconInvestor Watch on Shares of Rockwell Medical, Inc. (NASDAQ:RMTI) - The Tribune (NASDAQ:RMTI)
lakecitytribune.com - January 30 at 8:20 PM
News IconAnalysts Take the Wheel on Rockwell Medical, Inc. (NASDAQ:RMTI) Shares and Where They Might Be Headed - Aiken Advocate (NASDAQ:RMTI)
aikenadvocate.com - January 30 at 8:20 PM
News IconWhat Are the Numbers Saying About: Rockwell Medical, Inc. (NASDAQ:RMTI) - Gilbert Daily (NASDAQ:RMTI)
gilbertdaily.com - January 30 at 1:00 AM
News IconInvestors are Keeping Tabs on Rockwell Medical, Inc. (NASDAQ:RMTI) - The Tribune (NASDAQ:RMTI)
lakecitytribune.com - January 28 at 7:41 PM
News IconRockwell Medical, Inc. (NASDAQ:RMTI) EPS Estimate At $-0.11 - Transcript Daily (NASDAQ:RMTI)
transcriptdaily.com - January 28 at 7:41 PM
News IconTechnical Roundup on Shares of Rockwell Medical Inc. (RMTI) - Rives Journal (NASDAQ:RMTI)
rivesjournal.com - January 28 at 7:41 PM
finance.yahoo.com logoRockwell Medical will Present Data on Triferic Intravenous (IV) Administration at the 19th International Conference on Dialysis in Las Vegas, February 1-3, 2017 (NASDAQ:RMTI)
finance.yahoo.com - January 27 at 2:21 AM
News IconTechnical Indicator Review on Shares of Rockwell Medical Inc. (RMTI) - Sherwood Daily (NASDAQ:RMTI)
sherwooddaily.com - January 24 at 9:51 PM
News IconStock Update on Earnings & Estimates for Rockwell Medical, Inc. (NASDAQ:RMTI) - Aiken Advocate (NASDAQ:RMTI)
aikenadvocate.com - January 23 at 7:54 PM
News IconWhat The Charts Are Saying About Rockwell Medical, Inc. (NASDAQ:RMTI) - The Tribune (NASDAQ:RMTI)
lakecitytribune.com - January 23 at 7:54 PM
News IconEPS Target Of Rockwell Medical, Inc. (NASDAQ:RMTI)Set At $-0.11 - Transcript Daily (NASDAQ:RMTI)
transcriptdaily.com - January 23 at 7:54 PM
News IconPriming The Pump: Stock Volatility Spotted in Rockwell Medical, Inc. (NASDAQ:RMTI) - Wall Street Beacon (NASDAQ:RMTI)
wsbeacon.com - January 23 at 7:54 PM
News IconMarket Corner: Eye on Technicals for Rockwell Medical Inc. (RMTI) - Sherwood Daily (NASDAQ:RMTI)
sherwooddaily.com - January 22 at 7:18 PM
News IconWill The Needle Move For Rockwell Medical, Inc. (NASDAQ:RMTI) Shares This Earnings Season? - Wall Street Beacon (NASDAQ:RMTI)
wsbeacon.com - January 21 at 3:59 AM
News IconTrading Radar: Checking Technicals for Rockwell Medical Inc. (RMTI) - Rives Journal (NASDAQ:RMTI)
rivesjournal.com - January 21 at 3:59 AM
News IconRockwell Medical, Inc. (NASDAQ:RMTI) Projected to Achieve EPS Of $-0.1 - Stock Observer (NASDAQ:RMTI)
www.thestockobserver.com - January 17 at 7:57 PM
News IconRockwell Medical Inc RMTI Medical Equipment Deals and Alliances Profile Prices from USD $250 (NASDAQ:RMTI)
www.bioportfolio.com - January 17 at 12:17 PM
News IconStock ABR Rockwell Medical, Inc. (NASDAQ:RMTI) At 3.58 - Stock Observer (NASDAQ:RMTI)
www.thestockobserver.com - January 15 at 12:38 AM
capitalcube.com logoRockwell Medical, Inc. – Value Analysis (NASDAQ:RMTI) : January 11, 2017 (NASDAQ:RMTI)
www.capitalcube.com - January 11 at 9:45 PM
investornewswire.com logoSales Of Rockwell Medical, Inc. (NASDAQ:RMTI) Expected At $134.31 - Investor Newswire (NASDAQ:RMTI)
www.investornewswire.com - January 10 at 10:01 PM
capitalcube.com logoRockwell Medical, Inc. breached its 50 day moving average in a Bearish Manner : RMTI-US : January 10, 2017 (NASDAQ:RMTI)
www.capitalcube.com - January 10 at 10:01 PM
capitalcube.com logoETFs with exposure to Rockwell Medical, Inc. : January 9, 2017 (NASDAQ:RMTI)
www.capitalcube.com - January 9 at 8:24 PM
News IconRockwell Medical Inc RMTI Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:RMTI)
www.bioportfolio.com - January 8 at 7:24 PM
investornewswire.com logoExpected For Rockwell Medical, Inc. (NASDAQ:RMTI) Sales Of $134.31 - Investor Newswire (NASDAQ:RMTI)
www.investornewswire.com - January 4 at 5:29 AM
nasdaq.com logoImplied Volatility Surging for Rockwell Medical (RMTI) Stock Options - Nasdaq (NASDAQ:RMTI)
www.nasdaq.com - December 31 at 8:03 AM
investornewswire.com logoRockwell Medical, Inc. (NASDAQ:RMTI) Records An Impact Score Of 85 - Investor Newswire (NASDAQ:RMTI)
www.investornewswire.com - December 31 at 12:56 AM
zacks.com logoImplied Volatility Surging for Rockwell Medical (RMTI) Stock Options (NASDAQ:RMTI)
www.zacks.com - December 29 at 8:46 AM
capitalcube.com logoETFs with exposure to Rockwell Medical, Inc. : December 27, 2016 (NASDAQ:RMTI)
www.capitalcube.com - December 27 at 7:15 PM
News IconCommit To Buy Rockwell Medical At $5, Earn 19.9% Annualized Using Options (NASDAQ:RMTI)
www.stockoptionschannel.com - December 23 at 7:42 PM
News IconMarket Focus: Checking Up on Shares of Rockwell Medical, Inc. (NASDAQ:RMTI) - OIB News (NASDAQ:RMTI)
oibnews.com - December 22 at 2:11 AM
News IconTrading Indicator Check on Rockwell Medical Inc. (RMTI) - Yankee Analysts (NASDAQ:RMTI)
yankeeanalysts.com - December 20 at 2:18 PM
News IconFollowing the Numbers for Rockwell Medical, Inc. (NASDAQ:RMTI) - Liberty News (NASDAQ:RMTI)
libertynewsrecord.com - December 20 at 2:18 PM
News IconInvestor Chatter: Looking at Shares of Rockwell Medical, Inc. (NASDAQ:RMTI) - Liberty News (NASDAQ:RMTI)
libertynewsrecord.com - December 19 at 12:57 AM
News IconEquity Review: Looking Closer at Shares of Rockwell Medical, Inc. (NASDAQ:RMTI) - Business Daily Leader (NASDAQ:RMTI)
businessdailyleader.com - December 18 at 1:12 AM
News IconRockwell Medical, Inc. (NASDAQ:RMTI) EPS Estimate At $-0.1025 - Transcript Daily (NASDAQ:RMTI)
transcriptdaily.com - December 17 at 2:34 AM
News IconReviewing the Numbers for Rockwell Medical, Inc. (NASDAQ:RMTI) - Liberty News (NASDAQ:RMTI)
libertynewsrecord.com - December 17 at 2:34 AM
News IconIndicator Level Summary for Rockwell Medical Inc. (RMTI) - Yankee Analysts (NASDAQ:RMTI)
yankeeanalysts.com - December 17 at 2:34 AM
capitalcube.com logoETFs with exposure to Rockwell Medical, Inc. : December 16, 2016 (NASDAQ:RMTI)
www.capitalcube.com - December 16 at 9:33 PM
News IconRockwell Medical, Inc. (NASDAQ:RMTI) Stock ABR At 3.58 - Stock Observer (NASDAQ:RMTI)
www.thestockobserver.com - December 16 at 12:42 AM
News IconCompany Stock Watch: Rockwell Medical, Inc. (NASDAQ:RMTI) - OIB News (NASDAQ:RMTI)
oibnews.com - December 16 at 12:42 AM

Social

What is Rockwell Medical's stock symbol?

Rockwell Medical trades on the NASDAQ under the ticker symbol "RMTI."

Where is Rockwell Medical's stock going? Where will Rockwell Medical's stock price be in 2017?

5 brokers have issued 1 year target prices for Rockwell Medical's stock. Their predictions range from $5.00 to $12.00. On average, they expect Rockwell Medical's stock price to reach $8.00 in the next twelve months.

When will Rockwell Medical announce their earnings?

Rockwell Medical is scheduled to release their next quarterly earnings announcement on Monday, February, 27th 2017.

What are analysts saying about Rockwell Medical stock?

Here are some recent quotes from research analysts about Rockwell Medical stock:

  • According to Zacks Investment Research, "Rockwell Medical Technologies, Inc. manufactures hemodialysis concentrates and dialysis kits, and sells, distributes and delivers such concentrates and dialysis kits, as well as other ancillary hemodialysis products, to hemodialysis providers in the United States. Hemodialysis is a process which is able to duplicate kidney function in patients whose kidneys have failed to function properly. " (1/20/2017)

  • BTIG Research analysts commented, "We see RMTI shares as significantly undervalued at the current level with Triferic (projected peak sales of $180+ million), Calcitriol (peak sales of $48+ million) and a base business with a revenue run rate of ~$50 million," analyst Ling Wang wrote in a note.Related Link: Portolas AndexXa Still Approvable, But It Will Take TimeAlthough there is a near-term delay in Triferic ramp-up due to pursuing transitional add-on reimbursement, the analyst views the effort as worthwhile, given the added incentive for dialysis providers."Our Buy recommendation is not based on securing transitional add-on reimbursement. Rather, we believe Triferic's value proposition remains intact even without it," (8/19/2016)

Who owns Rockwell Medical stock?

Rockwell Medical's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Robert L Chioini (9.20%), State Street Corp (1.71%), Perritt Capital Management Inc. (0.09%), Metropolitan Life Insurance Co. NY (0.07%), State Board of Administration of Florida Retirement System (0.05%) and Cutter & CO Brokerage Inc. (0.05%). Company insiders that own Rockwell Medical stock include Kenneth L Holt, Raymond Dennis Pratt, Robert L Chioini and Ronald D Boyd.

Who sold Rockwell Medical stock? Who is selling Rockwell Medical stock?

Rockwell Medical's stock was sold by a variety of institutional investors in the last quarter, including Metropolitan Life Insurance Co. NY.

Who bought Rockwell Medical stock? Who is buying Rockwell Medical stock?

Rockwell Medical's stock was purchased by a variety of institutional investors in the last quarter, including Perritt Capital Management Inc., Cutter & CO Brokerage Inc., State Street Corp and Ladenburg Thalmann Financial Services Inc.. Company insiders that have bought Rockwell Medical stock in the last two years include Raymond Dennis Pratt and Robert L Chioini.

How do I buy Rockwell Medical stock?

Shares of Rockwell Medical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Rockwell Medical stock cost?

One share of Rockwell Medical stock can currently be purchased for approximately $5.83.

Rockwell Medical (NASDAQ:RMTI) Chart for Wednesday, February, 22, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Rockwell Medical (NASDAQ:RMTI)

Earnings History Chart

Earnings by Quarter for Rockwell Medical (NASDAQ:RMTI)

Dividend History Chart

Dividend Payments by Quarter for Rockwell Medical (NASDAQ:RMTI)

Last Updated on 2/22/2017 by MarketBeat.com Staff